Eosinophilic granulomatosis with polyangiitis (EGPA) : A 5-year study using the French nationwide hospital administrative database

G. Beltramo (DIJON, France)

Source: International Congress 2017 – Rare diseases
Session: Rare diseases
Session type: Thematic Poster
Number: 3854

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Beltramo (DIJON, France). Eosinophilic granulomatosis with polyangiitis (EGPA) : A 5-year study using the French nationwide hospital administrative database. 3854

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013


Cognitive impairment in patients with eosinophilic granulomatosis with polyangiitis (EGPA): Service evaluation in a regional severe asthma centre in North-west England
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020


Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018


Childhood sarcoidosis: long-term follow-up
Source: Eur Respir J 2008; 31: 592-598
Year: 2008



Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
Source: International Congress 2014 – ILDs 6
Year: 2014

ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA)
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017


Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012

Wegener granulomatosis : review of 16 cases
Source: Eur Respir J 2002; 20: Suppl. 38, 314s
Year: 2002

Granulomatosis with polyangiitis (Wegener&s)
Source: Eur Respir Mon 2011; 54: 1-14
Year: 2011


Twelve month outcomes with Reslizumab treatment of Eosinophilic Granulomatosis with Polyangiitis
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019

Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now?
Source: Eur Respir J 2015; 46: 1255-1258
Year: 2015


Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013


A case-series of Brazilian patients with Granulomatosis with poliangiitis
Source: International Congress 2017 – Novel and old entities
Year: 2017


Eosinophilic granulomatosis with polyangiitis
Source: Eur Respir Monogr 2019; 86: 188-209
Year: 2019


Eosinophilic granulomatosis with polyangiitis
Source: Eur Respir Monogr 2022; 95: 177-192
Year: 2022


Wegener's granulomatosis: our experience
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001

Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69
Year: 2005